Status:
COMPLETED
Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee Arthroplasty
Lead Sponsor:
University Health Network, Toronto
Conditions:
Knee Arthroplasty
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Patients undergoing total knee arthroscopy (knee replacement) surgery usually receive a femoral nerve block as part of their anesthetic care. Some centers administer the block with a single shot of lo...
Eligibility Criteria
Inclusion
- ASA physical status I-III
- 18-85 years of age, inclusive
- Able to communicate in English sufficiently to participate in the study
- Able to walk 30 metres without stopping prior to surgery
Exclusion
- Intended discharge to in-patient rehabilitation facility
- Patient refusal of FNB or spinal anesthetic or sciatic nerve block
- Contraindications to peripheral nerve block (e.g. allergy to local anesthetics, refusal)
- Significant peripheral neuropathy or neurological disorder affecting the lower extremity
- Contraindication to a component of multi-modal analgesia
- Pregnancy
- History of use of over 30mg oxycodone or equivalent per day (institutional threshold for acute pain service consultation pre-operatively)
- History of significant cognitive or psychiatric condition that may affect patient assessment
- Inability to provide informed consent
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00803348
Start Date
May 1 2009
End Date
October 1 2011
Last Update
April 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8